Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Shigeki Okada"'
Autor:
Sanae Fukuda, Hidenori Koyama, Kazuhiro Kondo, Hisako Fujii, Yoshinobu Hirayama, Tsutomu Tabata, Mikio Okamura, Tomoyuki Yamakawa, Shigeki Okada, Sumio Hirata, Hiroshi Kiyama, Osami Kajimoto, Yasuyoshi Watanabe, Masaaki Inaba, Yoshiki Nishizawa
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119578 (2015)
Fatigue is a predictor of cardiovascular events in patients with end-stage renal disease (ESRD) undergoing hemodialysis treatment. We hypothesized that multinutritional support would improve quality of life, fatigue symptoms, and potential quantitati
Externí odkaz:
https://doaj.org/article/800e6f099d2f4032b52b163ee2cca53b
Publikováno v:
Acta histochemica et cytochemica. 55(1)
Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter in the mature brain; however, it acts excitatory during development. This difference in action depends on the intracellular chloride ion concentration, primarily regulated by potassium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd81a4f5efb7f272d17019d765d79b64
https://pubmed.ncbi.nlm.nih.gov/35444351
https://pubmed.ncbi.nlm.nih.gov/35444351
Autor:
Toshikazu Takahashi, Hironori Kanehara, Katsuyuki Nagatoya, Nobuhisa Shibahara, Toru Inoue, Shigeki Okada, Hideaki Yasuda, Haruhiko Ueda, Kei Hirai, Nobuyuki Ueno, Kazuhiko Nishimoto
Publikováno v:
Clinical and Experimental Nephrology. 19:939-946
Postmenopausal women with end-stage renal failure are at an increased risk of fracture because of the effects of secondary hyperparathyroidism and postmenopausal osteoporosis. In the present study, we investigated the feasibility of using raloxifene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d8181a9ee6790ee184831be787b3ddb
https://doi.org/10.1007/s10157-014-1065-z
https://doi.org/10.1007/s10157-014-1065-z
Autor:
Akiyo Yamasaki, Koichiro Yoda, Shigeki Okada, Yoshihiro Tsujimoto, Masaaki Inaba, Hidenori Koyama, Senji Okuno, Shinsuke Yamada
Publikováno v:
Nephron. 134(2)
Background/Aims: Fatigue is a common symptom in patients receiving hemodialysis (HD) and is generally associated with anemia. However, it can be difficult to resolve, even when anemia has been treated using erythropoiesis-stimulating agents and iron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::affc4fc163c53a3f4090e0d86593b72d
https://pubmed.ncbi.nlm.nih.gov/27424040
https://pubmed.ncbi.nlm.nih.gov/27424040
Autor:
Shinsuke Yamada, Shigeki Okada, Yasuo Imanishi, Katsuhito Mori, Eiji Ishimura, Masanori Emoto, Masaaki Inaba, Yoshiki Nishizawa
Publikováno v:
Metabolism. 59:390-394
Sustained high glucose impairs bone metabolism in patients with type 2 diabetes mellitus (T2DM). In this study, the relationship between glycemic control and bone metabolism was examined in male hemodialysis (HD) patients with T2DM. To avoid the effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e853cdc0d931d84d4fdedb69c797d669
https://doi.org/10.1016/j.metabol.2009.08.008
https://doi.org/10.1016/j.metabol.2009.08.008
Autor:
Yoshiki Nishizawa, Yasuro Kumeda, Yasuo Imanishi, Masaaki Inaba, Shigeki Okada, Shinsuke Yamada, Senji Okuno, Mikio Okamura, Tomoyuki Yamakawa, Tsutomu Tabata, Eiji Ishimura
Publikováno v:
Journal of the American Society of Nephrology. 18:896-903
The significance of glycated albumin (GA), compared with casual plasma glucose (PG) and glycated hemoglobin (HbA(1c)), was evaluated as an indicator of the glycemic control state in hemodialysis (HD) patients with diabetes. The mean PG, GA, and HbA(1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9656869d34b137584dbc3b3c074b2165
https://doi.org/10.1681/asn.2006070772
https://doi.org/10.1681/asn.2006070772
Autor:
Daisuke Tsuruta, Chiharu Tateishi, Kae Hamamoto, Shinsuke Yamada, Yukari Mizukami, Kulsupa Nimmannitya, Shigeki Okada, Hitoshi Goto
Publikováno v:
The Journal of dermatology. 43(1)
Psoriasis is a common chronic inflammatory skin disease but psoriasis patients with renal impairment undergoing dialysis are not frequently seen. Furthermore, the published work contains little information on the treatment with biologic drugs of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0215da8aad3e410743ed7232d57406d9
https://pubmed.ncbi.nlm.nih.gov/26103788
https://pubmed.ncbi.nlm.nih.gov/26103788
Autor:
Masaaki Inaba, Yoshinobu Hirayama, Kazuhiro Kondo, Sumio Hirata, Hidenori Koyama, Osami Kajimoto, Hiroshi Kiyama, Tomoyuki Yamakawa, Yasuyoshi Watanabe, Sanae Fukuda, Tsutomu Tabata, Shigeki Okada, Mikio Okamura, Yoshiki Nishizawa, Hisako Fujii
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119578 (2015)
PLoS ONE
PLoS ONE
Background Fatigue is a predictor of cardiovascular events in patients with end-stage renal disease (ESRD) undergoing hemodialysis treatment. We hypothesized that multinutritional support would improve quality of life, fatigue symptoms, and potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db7c1b1b3e4351064a3c1cfed7c2828
http://europepmc.org/articles/PMC4352065?pdf=render
http://europepmc.org/articles/PMC4352065?pdf=render
Publikováno v:
Key Engineering Materials. :141-146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e62aa643928ecc212fce51d50871d0d1
https://doi.org/10.4028/www.scientific.net/kem.177-180.141
https://doi.org/10.4028/www.scientific.net/kem.177-180.141
Autor:
Shigeki Okada, Hideaki Yasuta, Koichiro Isurugi, Toshikazu Watsuji, Katsuo Hamada, Nobuhisa Shibahara
Publikováno v:
Journal of Japanese Society for Dialysis Therapy. 26:1493-1496
透析患者に対する手術療法の適応と安全性を調べるため, 術後合併症について検討した. 対象は当科および関連施設にて維持透析を受けている患者のうち, 1987年1月から1991年12月までの5年
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe3523beb8375fb663a2c7c15924a9a5
https://doi.org/10.4009/jsdt1985.26.1493
https://doi.org/10.4009/jsdt1985.26.1493